{ "cik": 1159036, "cik_padded": "0001159036", "entityName": "HALOZYME THERAPEUTICS, INC.", "fiscal_years": [ { "accn": "0001159036-26-000024", "filed": "2026-02-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 342372000.0, "capex": 6970000.0, "cash": 133820000.0, "eps_diluted": 2.56, "free_cash_flow": 644588000.0, "net_income": 316889000.0, "operating_cash_flow": 651558000.0, "operating_income": 469006000.0, "revenue": 1396611000.0, "stockholders_equity": 48814000.0, "total_assets": 2525323000.0, "total_liabilities": 2476509000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 50.73358053017577, "net_margin": 0.22689854225693482, "operating_margin": 0.3358172032154981, "revenue_growth_yoy": 0.3755323423852879, "roa_avg2y": 0.13811410390516038, "roa_period_end": 0.1254845419774025, "roe_avg2y": 1.5359288475286876 } }, { "accn": "0001159036-26-000024", "filed": "2026-02-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 250000000.0, "capex": 10696000.0, "cash": 115850000.0, "eps_diluted": 3.43, "free_cash_flow": 468368000.0, "net_income": 444091000.0, "operating_cash_flow": 479064000.0, "operating_income": 551475000.0, "revenue": 1015324000.0, "stockholders_equity": 363821000.0, "total_assets": 2063477000.0, "total_liabilities": 1699656000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 4.671681953488116, "net_margin": 0.43738845925044617, "operating_margin": 0.5431517426949427, "revenue_growth_yoy": 0.22438387319672043, "roa_avg2y": 0.23393236367869652, "roa_period_end": 0.21521490183801417, "roe_avg2y": 1.9841922663634393, "roe_period_end": 1.2206304748763814 } }, { "accn": "0001159036-26-000024", "filed": "2026-02-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 402383000.0, "capex": 15294000.0, "cash": 118370000.0, "eps_diluted": 2.1, "free_cash_flow": 373277000.0, "net_income": 281594000.0, "operating_cash_flow": 388571000.0, "operating_income": 337574000.0, "revenue": 829253000.0, "stockholders_equity": 83808000.0, "total_assets": 1733270000.0, "total_liabilities": 1649462000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 19.68143852615502, "net_margin": 0.3395754974657915, "operating_margin": 0.4070820364834375, "revenue_growth_yoy": 0.2562231486587206, "roa_avg2y": 0.15754475588854255, "roa_period_end": 0.16246401310817127, "roe_avg2y": 2.2207203299606477, "roe_period_end": 3.3599894998090876 } }, { "accn": "0001159036-26-000024", "filed": "2026-02-17", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 200002000.0, "capex": 4810000.0, "cash": 234195000.0, "eps_diluted": 1.44, "free_cash_flow": 235300000.0, "net_income": 202129000.0, "operating_cash_flow": 240110000.0, "operating_income": 267531000.0, "revenue": 660116000.0, "stockholders_equity": 169798000.0, "total_assets": 1841511000.0, "total_liabilities": 1671713000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 9.845304420546768, "net_margin": 0.3062022432420968, "operating_margin": 0.4052787691860218, "revenue_growth_yoy": 0.48906183032189665, "roa_avg2y": 0.13722546962938825, "roa_period_end": 0.10976258083714949, "roe_avg2y": 1.1022682964736292, "roe_period_end": 1.1904086031637593 } }, { "accn": "0001159036-25-000010", "filed": "2025-02-18", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 350058000.0, "capex": 1457000.0, "cash": 118719000.0, "eps_diluted": 2.74, "free_cash_flow": 297983000.0, "net_income": 402710000.0, "operating_cash_flow": 299440000.0, "operating_income": 275902000.0, "revenue": 443310000.0, "stockholders_equity": 196953000.0, "total_assets": 1104429000.0 }, "period_end": "2021-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.908416232433286, "operating_margin": 0.6223680945613679, "revenue_growth_yoy": 0.6566514944281262, "roa_avg2y": 0.4781776741573768, "roa_period_end": 0.36463185954008814, "roe_avg2y": 2.314425287356322, "roe_period_end": 2.044701020040314 } }, { "accn": "0001159036-24-000008", "filed": "2024-02-20", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 150117000.0, "capex": 2504000.0, "cash": 147703000.0, "eps_diluted": 0.91, "free_cash_flow": 52950000.0, "net_income": 129085000.0, "operating_cash_flow": 55454000.0, "operating_income": 144255000.0, "revenue": 267594000.0, "stockholders_equity": 151047000.0, "total_assets": 579924000.0 }, "period_end": "2020-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.4823912344820885, "operating_margin": 0.5390815937577076, "revenue_growth_yoy": 0.3653312380097147, "roa_avg2y": 0.2253189480170152, "roa_period_end": 0.2225895117291231, "roe_avg2y": 1.0632505806961765, "roe_period_end": 0.8546015478625858 } }, { "accn": "0001159036-23-000012", "filed": "2023-02-21", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 199998000.0, "capex": 4040000.0, "cash": 120179000.0, "eps_diluted": -0.5, "free_cash_flow": -89463000.0, "net_income": -72240000.0, "operating_cash_flow": -85423000.0, "operating_income": -67610000.0, "revenue": 195992000.0, "stockholders_equity": 91765000.0, "total_assets": 565874000.0 }, "period_end": "2019-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.36858647291726193, "operating_margin": -0.34496305971672314, "revenue_growth_yoy": 0.29059277501942554, "roa_avg2y": -0.14360087544055294, "roa_period_end": -0.12766092805112092, "roe_avg2y": -0.42412784894848704, "roe_period_end": -0.7872282460633139 } }, { "accn": "0001159036-22-000014", "filed": "2022-02-22", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 4663000.0, "cash": 57936000.0, "eps_diluted": -0.56, "free_cash_flow": -54163000.0, "net_income": -80330000.0, "operating_cash_flow": -49500000.0, "operating_income": -69330000.0, "revenue": 151862000.0, "stockholders_equity": 248887000.0, "total_assets": 440248000.0 }, "period_end": "2018-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.5289670885409121, "operating_margin": -0.4565329048741621, "revenue_growth_yoy": -0.5203545021840543, "roa_avg2y": -0.16732052826879595, "roa_period_end": -0.18246533771874035, "roe_avg2y": -0.35135909441818863, "roe_period_end": -0.3227569137801492 } }, { "accn": "0001159036-21-000014", "filed": "2021-02-23", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 1350000.0, "cash": 168740000.0, "eps_diluted": 0.45, "free_cash_flow": 132703000.0, "net_income": 62971000.0, "operating_cash_flow": 134053000.0, "operating_income": 81002000.0, "revenue": 316613000.0, "stockholders_equity": 208366000.0, "total_assets": 519945000.0 }, "period_end": "2017-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.19888949600932368, "operating_margin": 0.2558391474765723, "roa_avg2y": 0.16116243953625264, "roa_period_end": 0.12111088672840395, "roe_avg2y": 0.7160474173465616, "roe_period_end": 0.3022134129368515 } }, { "accn": "0001159036-20-000013", "filed": "2020-02-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 3137000.0, "cash": 66764000.0, "eps_diluted": -0.81, "free_cash_flow": -53520000.0, "net_income": -103023000.0, "operating_cash_flow": -50383000.0, "operating_income": -83210000.0, "stockholders_equity": -32481000.0, "total_assets": 261515000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.3939468099344206 } } ], "latest_filing": { "accn": "0001159036-26-000024", "filed": "2026-02-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001159036.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001159036.json" }, "ticker": "HALO" }